BG
Bellevue Group Portfolio holdings
AUM
$4.81B
1-Year Est. Return
29.28%
1 Year Est. Return
+29.28%
AUM
$4.81B
AUM Growth
+$276M
(+6.1%)
Holding
159
Top Buys
| 1 | +$93.8M | |
| 2 | +$46.4M | |
| 3 | +$25.1M | |
| 4 |
Akero Therapeutics
AKRO
|
+$19.2M |
| 5 |
Immunocore
IMCR
|
+$12.9M |
Top Sells
| 1 | +$105M | |
| 2 | +$105M | |
| 3 | +$36.5M | |
| 4 |
Moderna
MRNA
|
+$31.8M |
| 5 |
Stryker
SYK
|
+$31M |
Sector Composition
| 1 | Healthcare | 99.85% |
| 2 | Technology | 0.03% |
| 3 | Consumer Discretionary | 0.02% |
| 4 | Communication Services | 0.02% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Privia Health
PRVA
$2.96B
| $16.6M | 0.34% |
666,177
+35,480
|
|
||
52
Procept Biorobotics
PRCT
$1.7B
| $16.5M | 0.34% |
463,404
-25,874
|
|
||
53
Annexon
ANNX
$616M
| $15.7M | 0.33% |
5,157,290
|
|
||
54
Encompass Health
EHC
$11.5B
| $15.6M | 0.32% |
122,958
-8,783
|
|
||
55
Natera
NTRA
$32.3B
| $14.8M | 0.31% |
91,818
-55,673
|
|
||
56
Masimo
MASI
$7.74B
| $14.3M | 0.3% |
96,968
+7,295
|
|
||
57
Johnson & Johnson
JNJ
$495B
| $13.9M | 0.29% |
74,807
+6,596
|
|
||
58
Exact Sciences
EXAS
$19.2B
| $13.8M | 0.29% |
252,701
-31,500
|
|
||
59
Transmedics
TMDX
$5.14B
| $13.1M | 0.27% |
116,968
-13,549
|
|
||
|
ONC
60
BeOne Medicines Ltd
ONC
$37.1B
| $11.5M | 0.24% |
33,797
-4,901
|
|
||
61
Centene
CNC
$18.6B
| $10.1M | 0.21% |
281,949
+142,639
|
|
||
62
IQVIA
IQV
$38.9B
| $10M | 0.21% |
52,898
+19,198
|
|
||
63
Structure Therapeutics
GPCR
$2.1B
| $8.84M | 0.18% |
315,857
-32,670
|
|
||
64
Teva Pharmaceuticals
TEVA
$30.7B
| $8.57M | 0.18% |
424,056
+2,555
|
|
||
65
Regeneron Pharmaceuticals
REGN
$78.8B
| $8.47M | 0.18% |
15,057
-11,687
|
|
||
66
CareDx
CDNA
$884M
| $8.33M | 0.17% |
572,956
-179,415
|
|
||
67
Tenet Healthcare
THC
$18.9B
| $8.2M | 0.17% |
+40,372
|
|
||
68
Phreesia
PHR
$1.2B
| $7.36M | 0.15% |
313,057
-18,959
|
|
||
69
Axsome Therapeutics
AXSM
$7.51B
| $6.36M | 0.13% |
52,335
-3,918
|
|
||
70
Quest Diagnostics
DGX
$20.4B
| $6.29M | 0.13% |
33,015
-15,552
|
|
||
71
BrightSpring Health Services
BTSG
$6.47B
| $5.63M | 0.12% |
190,524
-1,182
|
|
||
|
OMDA
72
Omada Health Inc
OMDA
$1.08B
| $5.57M | 0.12% |
251,791
+1,791
|
|
||
73
Gilead Sciences
GILD
$154B
| $5.54M | 0.12% |
49,893
-1,523
|
|
||
74
BioMarin Pharmaceuticals
BMRN
$10.6B
| $5.47M | 0.11% |
101,033
-50,412
|
|
||
75
Ascendis Pharma
ASND
$12.9B
| $4.95M | 0.1% |
24,903
-3,752
|
|